3.8 billion-year long refinements and modifications made protein synthesis system flawless. Any kind of organism, from bacteria to human, has such a beautiful and amazing system. However, it is quite difficult to synthesize proteins artificially.
Is there any easier and affordable way to synthesize proteins? Our researches started from this simple question. Now we found the answer, and our findings can help the people who are struggling with synthesizing proteins as well as those who are suffering because these proteins are not available or very costly.
We launched the company, NUProtein, originating in Nagoya University, to provide these findings and technologies globally so you do not have to struggle with your proteins anymore.
|Addr.||3-20 Showa-cho, Tokushima, Tokushima, 770-0942 JAPAN|
|Mitsubishi UFJ||Motoyama branch||0123111|
Nagoya University of Commerce and Business (MBA), Graduate school of Economics, Nagoya University (PhD candidate)
Director of Tokushima Lab.
Dec 9, 2016, we received the highest award from NEDO (New Energy and Industrial Technolgy Development organization), one of the biggest grant agency run by MITI Japan.
We received several entrepreneur courses at Stanford Research Institute (SRI)
As the demo day hold by JETRO and SV Forum, we presented and received the highest award.
Aug 2nd, 2016, we established and registered the company, NUProtein Co., Ltd.
NUProtein is accredited as “Nagoya University originated” since the founder is PhD candidate at graduate school of Economics , designated professor at Nagoya University and got the exclusive right to use filed patent.
NEDO (New Energy and Industrial Technolgy Development organization), one of the biggest grant agency run by MITI Japan accept our proposal on Dec., 22, 2016.
We will get fund up to 35,000,000 yen for one year R&D.
We received capital loan from Japan Finance Corporation.
We received regional award from independents club.
BIOTECH grand prix run by Leave a nest, co.. We received Company Award from Rohto Pharmaceutical, appreciated very low cost cytokine for stem cell culture and for regenerative medicine.
The Company implemented a third-party allotment with SRC Management Co., Ltd. as the underwriter.
Through this funding, we will strengthen the system, manufacture and sell growth factors manufactured in-house, and develop a translation solution for mass synthesis that can synthesize proteins quickly and inexpensively worldwide. We will do our utmost to rectify the “health gap” and contribute to the field of cultured meat using the same stem cell culture technology, and to contribute “food security” and “sustainable production and consumption”.
In the strategic infrastructure technology advancement support project (SAPPOIN), as a consortium of four organizations including our company (Tokushima Industry Promotion Organization, Nara Institute of Science and Technology, Tokushima Prefectural Institute of Technology, our company) “Development of cell-free synthesis system for high protein expression that realizes cost reduction” was selected.
Japan Patent Office stated that NUProtein’s products are NOT falling under the technical scope of claim 3 of CellFreeScience’s JP3573358 patent as the conclusion of Hantei service.
What is Hantei
The Japan Patent Office, having a high degree of expertise regarding technology, design and goods, will render an official Hantei in a strictly neutral manner regarding whether the subject article falls under the technical scope of the patented invention in question within as soon as three months from the time of filing of theHantei demand
(quoted from Japan Patent Office web site)